Biotech Values

[DewDiligence]

>ZGEN – I made a similar comment (albeit without the term 'disingenuous')<

Other than the two “disingenuous” slides, I thought the IFN-lambda presentation was quite good.

The lambda program was in the slow lane until fairly recently, but ZGEN finally seems to have woken up and decided to allocate its resources in a way that’s commensurate with each program’s prospects. Lambda is clearly a much bigger story than Recothrom.